TransMedics Group Inc vs Warner Music Group Corp — how do they compare? TransMedics Group Inc trades at $77.87 (market cap $2.74B), while Warner Music Group Corp trades at $28.72 (market cap $15.12B). The key difference: Warner Music Group Corp is far larger — about 5.5× TransMedics Group Inc's market cap, and Warner Music Group Corp pays a 2.77% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and Warner Music Group Corp for 96 Days on average.
| TMDX | WMG | |
|---|---|---|
Market Cap | $2.74B | $15.12B |
Volume | 949,331 | 2,966,414 |
Sector | Health | Media |
52-Week High | $150.42 | $34.72 |
52-Week Low | $61.99 | $23.65 |
Typical Hold Time | 24 Days | 96 Days |
Enterprise Value | $3.13B | $19.42B |
Dividend Yield | — | 2.77% |
Signals from Pluang's Aura AI — not financial advice
TMDX trades at $79.00, down 2.55% amid bearish technical signals. The stock shows strong profitability with 22.69% net margin and 36.28% ROE, though recent earnings misses and margin compression from 2025 to 2026 raise concerns. Analyst consensus remains bullish with a $99.75 price target, but multiple legal investigations into fiduciary duties create uncertainty. Revenue growth continues with 2026 guidance at $668M.
The stock presents a growth opportunity with analyst upside potential, but faces near-term headwinds from earnings volatility and legal scrutiny. Execution on 2026 guidance and resolution of governance concerns will be critical for sustained momentum. Current valuation at 20.47 P/E appears reasonable given growth prospects if operational targets are met.
Warner Music Group (WMG) trades at $28.91, up 2.66% with strong technical momentum and bullish moving average signals. The company reported solid Q2 2026 earnings, beating EPS estimates with $0.38 vs. $0.34 expected, while revenue growth continues with 2026 projections showing $7.3B. Recent AI partnerships with Suno and NetEase Cloud Music highlight strategic positioning in the evolving music industry landscape.
WMG presents a compelling investment case with 66.7% analyst buy ratings and a $39.50 consensus price target representing 36.6% upside. However, risks include recent CFO departure, ongoing AI copyright litigation, and margin pressure from 2025's 5.44% net margin. The stock's premium valuation at 23.12 P/E requires continued execution on streaming growth and AI initiatives.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →